Fingerprint
Dive into the research topics of 'Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis
Fieke W. Hoff, Rahul Banerjee, Adeel M. Khan, Georgia McCaughan, Bo Wang, Xiaoliang Wang, James Roose, Larry D. Anderson, Andrew J. Cowan, S. Vincent Rajkumar, Gurbakhash Kaur
Research output: Contribution to journal › Article › peer-review
5
Scopus
citations